Osteoporosis and Osteopenia are systemic conditions that may alter clinical therapy and results. The incidence is rising due to increased lifespan, reduced utilization of hormone replacement therapy, medications that alter bone metabolism, and poor diet/lack of proper exercise. The dental clinician should be aware of the effects of decreasing bone mineral density (BMD)on their periodontal/implant patients and need to alter therapy. Oral bone turnover is more active than long bones, therefore, the impact of low bone density can be recognized by the dental teams first.
New literature with regard to decreasing BMD and the effects on alveolar bone and tooth loss will be introduced. In light of warnings of "osteochemonecrosis", the clinician should also be aware of the effects of long term IV bisphophonate therapy. *This session will be removed from the virtual platform immediately following the conclusion of conference on June 28.
Understand the diagnosis and development of osteoporosis and osteopenia
Apply the implications of low BMD in periodontal/implant therapy
Understand the clinical application treatment needs of patients with or susceptible to osteoporosis
Understand the bisphosphonates used to treat bone density and their impact on oral bone: differences, potencies, binding, urinary excretion
Multiple new medications and therapies for treatment